海思科(002653.SZ)获得1类创新药苯磺酸克利加巴林胶囊新适应症药品注册证书

智通财经网07-07

智通财经APP讯，海思科(002653.SZ)发布公告，公司于2024年7月5日收到国家药品监督管理局下发的1类创新药苯磺酸克利加巴林胶囊(商品名：思美宁，研发代号：HSK16149胶囊)《药品注册证书》。本品用于治疗成人糖尿病性周围神经病理性疼痛和带状疱疹后神经痛。据称，苯磺酸克利加巴林胶囊是该公司自主研发的，具有独立知识产权的口服γ-氨基丁酸(γ-aminobutyric acid，GABA...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2449375827?lang=zh_CN&edition=full","thumbnail":"https://img.zhitongcaijing.com/astock/22.jpg?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250","is_english":false,"pubTime":"2024-07-07 15:47","share_image_url":"https://static.laohu8.com/6ca2dcdccfa2217fb20a0351f4efe814","id":"2449375827","market":"us","top_or_hot":-1,"title":"海思科(002653.SZ)获得1类创新药苯磺酸克利加巴林胶囊新适应症药品注册证书","media":"智通财经网","content":"<div>\n<p>智通财经APP讯，海思科(002653.SZ)发布公告，公司于2024年7月5日收到国家药品监督管理局下发的1类创新药苯磺酸克利加巴林胶囊(商品名：思美宁，研发代号：HSK16149胶囊)《药品注册证书》。本品用于治疗成人糖尿病性周围神经病理性疼痛和带状疱疹后神经痛。据称，苯磺酸克利加巴林胶囊是该公司自主研发的，具有独立知识产权的口服γ-氨基丁酸(γ-aminobutyric  acid，GABA...</p>\n\n<a href=\"http://www.zhitongcaijing.com/content/detail/1146581.html\">网页链接</a>\n\n</div>\n","source":"highlight_zhitongcaijin","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>海思科(002653.SZ)获得1类创新药苯磺酸克利加巴林胶囊新适应症药品注册证书</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n海思科(002653.SZ)获得1类创新药苯磺酸克利加巴林胶囊新适应症药品注册证书\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-07-07 15:47 北京时间&nbsp;&nbsp;&nbsp;<a href=http://www.zhitongcaijing.com/content/detail/1146581.html><strong>智通财经网</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>智通财经APP讯，海思科(002653.SZ)发布公告，公司于2024年7月5日收到国家药品监督管理局下发的1类创新药苯磺酸克利加巴林胶囊(商品名：思美宁，研发代号：HSK16149胶囊)《药品注册证书》。本品用于治疗成人糖尿病性周围神经病理性疼痛和带状疱疹后神经痛。据称，苯磺酸克利加巴林胶囊是该公司自主研发的，具有独立知识产权的口服γ-氨基丁酸(γ-aminobutyric  acid，GABA...</p>\n\n<a href=\"http://www.zhitongcaijing.com/content/detail/1146581.html\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK0077","symbol_name":"质押式回购","start_time":0,"source_url":"http://www.zhitongcaijing.com/content/detail/1146581.html","article_id":"2449375827","we_media_id":null,"thumbnails":["https://img.zhitongcaijing.com/astock/22.jpg?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250"],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2449375827","pubTimestamp":1720338474,"sourceInfo":{"source_id":"highlight_zhitongcaijin","name":"智通财经网"},"weMediaInfo":null,"summary":"海思科(002653.SZ)发布公告，公司于2024年7月5日收到国家药品监督管理...","collect":0,"end_time":0,"defaultTopTitle":"zhitongcaijing.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"159992":"创新药","BK0077":"质押式回购","BK1574":"生物医药B类股","BK1161":"生物科技","BK0033":"西藏振兴","BK0188":"融资融券","BK0028":"国家队","002653":"海思科","BK0239":"医药制造","06978":"永泰生物-B"},"translate_title":"Haisco (002653. SZ) obtained the drug registration certificate for new indications of Class 1 innovative drug Crigabalin Besylate Capsules","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"159992":1,"002653":1,"06978":1},"content_text":"智通财经APP讯，海思科(002653.SZ)发布公告，公司于2024年7月5日收到国家药品监督管理局下发的1类创新药苯磺酸克利加巴林胶囊(商品名：思美宁，研发代号：HSK16149胶囊)《药品注册证书》。本品用于治疗成人糖尿病性周围神经病理性疼痛和带状疱疹后神经痛。据称，苯磺酸克利加巴林胶囊是该公司自主研发的，具有独立知识产权的口服γ-氨基丁酸(γ-aminobutyric  acid，GABA)类似物，其可与中枢神经系统中电压敏感型钙离子通道α2δ受体结合，减少中枢神经系统电压依赖性钙通道的钙离子内流，从而减少谷氨酸盐、去甲肾上腺素(Noradrenaline，NE)和P物质等兴奋性神经递质的释放，具有镇痛、抗癫痫和抗焦虑的活性。","kind":null,"is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.26.2","shortVersion":"4.26.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2449375827"}